Human clinical data from AD patients reported elevated plasma levels of the pro-inflammatory cytokines TNFa, IL6, and IL1b in APOE4 carriers, carrying either one or two copies, compared to APOE2 and APOE3 carriers [83,84]. This evidence concerns the gene APOE and Alzheimer disease.